US4853221A
(en)
|
1980-11-13 |
1989-08-01 |
Warner-Lambert Company |
Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US5294430A
(en)
|
1988-09-12 |
1994-03-15 |
University Of Rochester |
Use of dithiocarbamates to treat myelosuppression
|
US5035878A
(en)
|
1988-09-12 |
1991-07-30 |
University Of Rochester |
Use of dithiocarbamates to counteract myelosuppression
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5597798A
(en)
|
1990-03-05 |
1997-01-28 |
The Regents Of The University Of California |
Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
|
ES2187500T3
(es)
|
1991-02-21 |
2003-06-16 |
Smithkline Beecham Corp |
Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
US5795870A
(en)
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
KR970702725A
(ko)
|
1994-04-26 |
1997-06-10 |
노부히로 나리따 |
비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
WO1998055650A1
(en)
|
1997-06-04 |
1998-12-10 |
Rijksuniversiteit Te Leiden |
A diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
AU4543899A
(en)
|
1998-06-08 |
1999-12-30 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
ES2255287T3
(es)
|
1998-07-09 |
2006-06-16 |
Cephalon, Inc. |
Composiciones para el tratamiento de la leucemia linfocitica cronica.
|
WO2001007084A1
(en)
|
1999-07-23 |
2001-02-01 |
Regents Of The University Of California |
Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
US20020037328A1
(en)
*
|
2000-06-01 |
2002-03-28 |
Brown Dennis M. |
Hexitol compositions and uses thereof
|
GB0014820D0
(en)
|
2000-06-16 |
2000-08-09 |
Medical Res Council |
Methods and materials relating to plasmid vectors
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
AU2002324451A1
(en)
|
2001-06-21 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
EP1585817B1
(en)
|
2002-02-20 |
2009-09-02 |
The General Hospital Corporation |
Conjugates comprising a biodegradable polymer and uses therefor
|
EP1654377A4
(en)
|
2002-03-01 |
2010-03-24 |
Roger Williams Hospital |
PROCESSES AND COMPOSITIONS RELATED TO THE SHC PROTEIN FOR THE PROGNOSIS OF BREAST, PROSTATE AND EGG CANCER
|
US7074575B2
(en)
|
2002-04-11 |
2006-07-11 |
Zymogenetics, Inc. |
Use of interleukin-19 to treat ovarian cancer
|
EP1496925A4
(en)
|
2002-04-11 |
2007-05-30 |
Zymogenetics Inc |
USE OF INTERLEUKIN-24 FOR THE TREATMENT OF OVARIAL CARCINOMA
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20060058217A1
(en)
|
2003-01-21 |
2006-03-16 |
White Hillary D |
Compositions and methods for treatment of ovarian cancer
|
US20070207952A1
(en)
|
2003-03-24 |
2007-09-06 |
Sequoia Pharmaceuticals |
Long Acting Biologically Active Conjugates
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
ZA200508298B
(en)
|
2003-04-11 |
2007-01-31 |
Ptc Therapeutics Inc |
1,2,4-oxadiazole benzoic acid compounds
|
US7405300B2
(en)
|
2003-09-04 |
2008-07-29 |
Aventis Pharmaveuticals Inc. |
Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
|
TW200524940A
(en)
|
2003-10-02 |
2005-08-01 |
Salmedix Inc |
Indole derivatives
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
DK1692113T3
(en)
|
2003-11-14 |
2018-01-08 |
Lorus Therapeutics Inc |
ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES
|
AR048427A1
(es)
|
2004-03-11 |
2006-04-26 |
Altana Pharma Ag |
Derivados de sulfonilpirroles con actividad inhibitoria de la histona deacetilasa, composiciones farmaceuticas que los contienen y el uso de las mismas para el tratamiento de enfermedades relacionadas.
|
WO2005099824A1
(en)
|
2004-03-30 |
2005-10-27 |
Synta Pharmaceuticals, Corp. |
1-glyoxylamide indolizines for treating lung and ovarian cancer
|
WO2005098446A2
(en)
|
2004-03-31 |
2005-10-20 |
The Johns Hopkins University |
Biomarkers for ovarian cancer
|
US8957056B2
(en)
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
AU2005259188B2
(en)
|
2004-06-30 |
2011-03-31 |
Janssen Pharmaceutica N.V. |
Quinazolinone derivatives as PARP inhibitors
|
KR101443473B1
(ko)
|
2004-07-22 |
2014-09-22 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
Vh 결합 영역의 분리 방법
|
EP2633858A3
(en)
|
2004-08-20 |
2013-12-11 |
Buck Institute for Age Research |
Small molecules that replace or agonize p53 function
|
JP4834553B2
(ja)
|
2004-09-17 |
2011-12-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
医薬組成物
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
CA2588607A1
(en)
|
2004-11-23 |
2006-06-01 |
Ptc Therapeutics, Inc. |
Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
|
US8975248B2
(en)
|
2004-12-15 |
2015-03-10 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Combinations of therapeutic agents for treating cancer
|
MX2007008771A
(es)
|
2005-01-19 |
2007-09-11 |
Mgi Gp Inc |
Compuestos de diazabenzo [des] antracen-3-ona y metodos para inhibir parp.
|
WO2006081158A2
(en)
|
2005-01-25 |
2006-08-03 |
The Regents Of The University Of California |
Predictive and therapeutic markers in overian cancer
|
EP1702989A1
(en)
|
2005-03-16 |
2006-09-20 |
Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon |
Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment
|
WO2006110683A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
|
GEP20115226B
(en)
|
2005-04-26 |
2011-06-10 |
Pfizer |
P-cadherin antibodies
|
AR053272A1
(es)
|
2005-05-11 |
2007-04-25 |
Hoffmann La Roche |
Determinacion de responsivos a la quimioterapia
|
EP1915340B1
(en)
|
2005-06-15 |
2013-08-07 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
CA2611173C
(en)
|
2005-06-24 |
2019-11-12 |
Ciphergen Biosystems, Inc. |
Biomarkers for ovarian cancer
|
MX2008000745A
(es)
*
|
2005-07-15 |
2008-03-14 |
Schering Corp |
Derivados de quinazolina utiles en el tratamiento del cancer.
|
WO2007013946A2
(en)
|
2005-07-20 |
2007-02-01 |
University Of South Florida |
Method of predicting responsiveness to chemotherapy and selecting treatments
|
US8101799B2
(en)
|
2005-07-21 |
2012-01-24 |
Ardea Biosciences |
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
|
CA2618377A1
(en)
|
2005-08-12 |
2007-02-22 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate hsp90 activity
|
US7507536B2
(en)
|
2005-10-07 |
2009-03-24 |
The Johns Hopkins University |
Methylation markers for diagnosis and treatment of ovarian cancer
|
US8124095B2
(en)
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
EP1938823A1
(en)
|
2005-10-19 |
2008-07-02 |
Chugai Seiyaku Kabushiki Kaisha |
Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug
|
WO2007050599A2
(en)
|
2005-10-27 |
2007-05-03 |
The Brigham & Women's Hospital, Inc. |
Ginkgolides in the treatment and prevention of ovarian cancer
|
EP3173084B1
(en)
|
2005-11-11 |
2019-10-23 |
Boehringer Ingelheim International GmbH |
Quinazoline derivatives for the treatment of cancer diseases
|
ATE473756T1
(de)
|
2005-11-16 |
2010-07-15 |
Pantarhei Bioscience Bv |
Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
|
EP1971583B1
(en)
|
2005-12-20 |
2015-03-25 |
Incyte Corporation |
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
|
JP5324922B2
(ja)
|
2005-12-23 |
2013-10-23 |
エコバイオティクス リミテッド |
スピロケタール
|
EP1986625B1
(en)
|
2006-02-10 |
2012-08-01 |
Ramot at Tel-Aviv University Ltd. |
Treatment of ovarian cancer
|
WO2007109120A2
(en)
|
2006-03-17 |
2007-09-27 |
Ambit Biosciences Corporation |
Imidazolothiazole compounds for the treatment of disease
|
AU2007246793B2
(en)
|
2006-04-26 |
2013-02-07 |
F. Hoffmann-La Roche Ag |
Thieno [3, 2-D] pyrimidine derivative useful as PI3K inhibitor
|
IL282783B2
(en)
|
2006-05-18 |
2023-09-01 |
Caris Mpi Inc |
A system and method for determining a personalized medical intervention for a disease stage
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
US8318790B2
(en)
|
2006-05-25 |
2012-11-27 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
TW200800260A
(en)
|
2006-05-25 |
2008-01-01 |
Synta Pharmaceuticals Corp |
Method for treating proliferative disorders associated with protooncogene products
|
CN101506214A
(zh)
|
2006-06-20 |
2009-08-12 |
艾博特公司 |
作为parp抑制剂的吡唑并喹唑啉酮
|
AU2007289065B2
(en)
|
2006-09-01 |
2013-03-14 |
Senhwa Biosciences, Inc. |
Serine-threonine protein kinase and PARP modulators
|
US7547781B2
(en)
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
JP5721949B2
(ja)
|
2006-10-12 |
2015-05-20 |
アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited |
複合薬剤
|
TWI404716B
(zh)
|
2006-10-17 |
2013-08-11 |
Kudos Pharm Ltd |
酞嗪酮(phthalazinone)衍生物
|
MX2009006700A
(es)
|
2006-12-21 |
2009-06-30 |
Vertex Pharma |
Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
|
WO2008098139A2
(en)
|
2007-02-07 |
2008-08-14 |
The Regents Of The University Of Colorado |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
WO2008100624A2
(en)
|
2007-02-16 |
2008-08-21 |
Merrimack Pharmaceuticals, Inc. |
Antibodies against erbb3 and uses thereof
|
AU2008221358A1
(en)
|
2007-02-28 |
2008-09-04 |
Inotek Pharmaceuticals Corporation |
Indenoisoquinolinone analogs and methods of use thereof
|
WO2008109440A2
(en)
|
2007-03-02 |
2008-09-12 |
Genentech, Inc. |
Predicting response to a her dimerisation inhibitor based on low her3 expression
|
DK2134691T3
(da)
|
2007-03-08 |
2012-05-07 |
Janssen Pharmaceutica Nv |
Quinolinonderivativer som parp- og tank-inhibitorer
|
US8030060B2
(en)
|
2007-03-22 |
2011-10-04 |
West Virginia University |
Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer
|
EA017029B1
(ru)
|
2007-04-06 |
2012-09-28 |
Ньюрокрайн Байосайенсиз, Инк. |
Антагонисты рецептора гонадотропин-рилизинг-фактора и способы их применения
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
JP2008295328A
(ja)
|
2007-05-30 |
2008-12-11 |
Fujifilm Corp |
卵巣癌の検出方法、及び抑制方法
|
BRPI0813331A2
(pt)
|
2007-06-08 |
2014-12-23 |
Janssen Pharmaceutica Nv |
Derivados de piperidina/piperazina
|
MY150234A
(en)
|
2007-06-29 |
2013-12-31 |
Ahn Gook Pharmaceutical Company Ltd |
Predictive markers for ovarian cancer
|
WO2009016565A1
(en)
|
2007-07-27 |
2009-02-05 |
Piramal Life Sciences Limited |
Tricyclic compounds for the treatment of inflammatory disorders
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
ES2514517T3
(es)
|
2007-08-10 |
2014-10-28 |
Mitsubishi Tanabe Pharma Corporation |
Nueva sal de compuesto de isoquinolina y cristal de la misma
|
EP2193210B1
(en)
|
2007-09-17 |
2014-11-12 |
Koninklijke Philips N.V. |
Method for the analysis of ovarian cancer disorders
|
KR101596526B1
(ko)
|
2007-10-03 |
2016-02-22 |
에이자이 아이엔씨. |
Parp 억제제 화합물, 조성물 및 사용 방법
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain vehicles, installations and methods
|
WO2009058102A1
(en)
|
2007-11-02 |
2009-05-07 |
Agency For Science, Technology And Research |
Methods and compounds for preventing and treating a tumour
|
IL187247A0
(en)
|
2007-11-08 |
2008-12-29 |
Hadasit Med Res Service |
Novel synthetic analogs of sphingolipids
|
JP2011503071A
(ja)
|
2007-11-12 |
2011-01-27 |
バイパー サイエンシズ,インコーポレイティド |
Parp阻害剤単独又は抗腫瘍剤との組み合わせによる子宮がん及び卵巣がんの治療
|
US20090170842A1
(en)
|
2007-11-14 |
2009-07-02 |
University Of Kansas |
Brca1-based breast or ovarian cancer prevention agents and methods of use
|
ES2524787T3
(es)
|
2007-11-15 |
2014-12-12 |
Msd Italia S.R.L. |
Derivados de piridazinona como inhibidores de PARP
|
WO2009065230A1
(en)
|
2007-11-23 |
2009-05-28 |
British Columbia Cancer Agency Branch |
Methods for detecting lung cancer and monitoring treatment response
|
CA2737137C
(en)
|
2007-12-05 |
2018-10-16 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
EP2229443A1
(en)
|
2007-12-06 |
2010-09-22 |
Novartis Forschungsstiftung, Zweigniederlassung |
Use of protease nexin 1 inhibitors to reduce metastasis
|
US8741889B2
(en)
|
2008-01-11 |
2014-06-03 |
Hoffmann-La Roche Inc |
Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
|
ES2494365T3
(es)
|
2008-01-30 |
2014-09-15 |
Genentech, Inc. |
Compuestos de pirazolopirimidina que inhiben PI3K y métodos de uso
|
US8642347B2
(en)
|
2008-01-31 |
2014-02-04 |
The Brigham And Women's Hospital, Inc. |
Urinary CA125 peptides as biomarkers of ovarian cancer
|
CN101998959B
(zh)
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
US20090275519A1
(en)
|
2008-02-08 |
2009-11-05 |
Aileron Therapeutics, Inc. |
Therapeutic peptidomimetic macrocycles
|
US8828657B2
(en)
|
2008-02-14 |
2014-09-09 |
Decode Genetics Ehf. |
Susceptibility variants for lung cancer
|
KR20100132489A
(ko)
|
2008-02-20 |
2010-12-17 |
액테리온 파마슈티칼 리미티드 |
난소암을 치료하기 위하여 파클리탁셀을 포함하는 조합
|
FR2928151B1
(fr)
|
2008-03-03 |
2010-12-31 |
Sanofi Aventis |
Derives platine-carbene n-heterocyclique, leur preparation et leur application en therapeutique
|
CA2972138A1
(en)
|
2008-03-17 |
2009-09-24 |
Ambit Biosciences Corporation |
Raf kinase modulator compounds and methods of use thereof
|
US8476026B2
(en)
|
2008-04-01 |
2013-07-02 |
The Brigham And Women's Hospital, Inc. |
Biomarkers of ovarian cancer
|
EP2291349A2
(en)
|
2008-04-14 |
2011-03-09 |
The Board of Regents of The University of Texas System |
Small molecule inhibitors of the pleckstrin homology domain and methods for using same
|
EP2265286B1
(en)
|
2008-04-16 |
2016-06-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
|
AR071717A1
(es)
|
2008-05-13 |
2010-07-07 |
Array Biopharma Inc |
Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
|
EP2288741B1
(en)
|
2008-05-14 |
2015-01-28 |
University Health Network |
Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
|
JP5599784B2
(ja)
|
2008-06-11 |
2014-10-01 |
ジェネンテック, インコーポレイテッド |
ジアザカルバゾール類と使用方法
|
WO2010005879A1
(en)
|
2008-07-09 |
2010-01-14 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
JP2011527708A
(ja)
|
2008-07-11 |
2011-11-04 |
ニュメディックス |
減少した抗菌活性および神経保護作用の利点を有するテトラサイクリン誘導体
|
US8012976B2
(en)
|
2008-08-06 |
2011-09-06 |
Biomarin Pharmaceutical Inc. |
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
|
WO2010017545A2
(en)
|
2008-08-08 |
2010-02-11 |
Synta Pharamceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
UA104868C2
(uk)
|
2008-08-15 |
2014-03-25 |
Меррімак Фармасьютікалз, Інк. |
Спосіб лікування пацієнта, що має неопластичну пухлину, відповідно до спрогнозованої реакції
|
KR101353857B1
(ko)
|
2008-08-22 |
2014-01-21 |
노파르티스 아게 |
Cdk 억제제로서 피롤로피리미딘 화합물
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
KR100961410B1
(ko)
|
2008-10-14 |
2010-06-09 |
(주)네오팜 |
단백질 키나제 억제제로서 헤테로사이클릭 화합물
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
JP5765634B2
(ja)
|
2008-10-21 |
2015-08-19 |
スレッシュホールド ファーマシューティカルズ, インコーポレイテッド |
低酸素活性化型プロドラッグを用いるがんの処置
|
US8946289B2
(en)
|
2008-11-19 |
2015-02-03 |
Duke University |
Manassatin compounds and methods of making and using the same
|
SI2370442T1
(sl)
|
2008-11-26 |
2013-06-28 |
Pfizer Inc. |
3-aminociklopentankarboksiamidi kot modulatorji kemokinskega receptorja
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8058075B2
(en)
|
2008-12-10 |
2011-11-15 |
University Of Utah Research Foundation |
Molecular fluorescence sensor for highly sensitive and selective detection of mercury
|
CA2747942C
(en)
|
2008-12-22 |
2016-12-06 |
F. Hoffmann-La Roche Ag |
Armet as a marker for cancer
|
US7928105B2
(en)
|
2009-01-23 |
2011-04-19 |
Takeda Pharmaceutical Company Limited |
Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones
|
EP2396007A1
(en)
|
2009-02-10 |
2011-12-21 |
Celgene International Sarl |
Methods for treating non-small cell lung cancer using 5-azacytidine
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
KR20110124787A
(ko)
|
2009-02-27 |
2011-11-17 |
암비트 바이오사이언시즈 코포레이션 |
Jak 키나아제 조절 퀴나졸린 유도체 및 이의 사용 방법
|
US8969001B2
(en)
|
2009-03-12 |
2015-03-03 |
Rush University Medical Center |
Materials and methods for predicting recurrence of non-small cell lung cancer
|
CN101869558A
(zh)
*
|
2009-04-22 |
2010-10-27 |
北京大学 |
二乙酰二脱水卫矛醇的抗血管生成及肿瘤转移作用
|
PT104607B
(pt)
|
2009-05-20 |
2012-03-23 |
Univ De Coimbra |
Derivados triterpenóides úteis como agentes antiproliferativos
|
EP2443117B1
(en)
|
2009-06-15 |
2016-03-23 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
US8980268B2
(en)
|
2009-07-29 |
2015-03-17 |
Regeneron Pharamceuticals, Inc. |
Methods for treating cancer by administering an anti-Ang-2 antibody
|
US8541417B2
(en)
|
2009-07-30 |
2013-09-24 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-ribose) polymerase (PARP) inhibitors
|
WO2011014697A1
(en)
|
2009-07-31 |
2011-02-03 |
The Translational Genomics Research Institute |
Methods of assessing a risk of cancer progression
|
JP5722781B2
(ja)
|
2009-08-26 |
2015-05-27 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
US20130203861A1
(en)
|
2009-09-09 |
2013-08-08 |
Golden Biotechnology Corporation |
Methods and compositions for treating ovarian cancer
|
WO2011038139A1
(en)
|
2009-09-23 |
2011-03-31 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
CN102762574B
(zh)
|
2009-09-28 |
2015-12-02 |
霍夫曼-拉罗奇有限公司 |
苯并氧杂*pi3k抑制剂化合物和使用方法
|
JP2013507380A
(ja)
|
2009-10-08 |
2013-03-04 |
サンフォード−バーンハム メディカル リサーチ インスティテュート |
抗癌剤としてのアポゴシポロン誘導体
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
US8981084B2
(en)
|
2010-01-13 |
2015-03-17 |
Tempero Pharmaceuticals, Inc. |
Oxadiazole HDAC inhibitors
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
MX2012009809A
(es)
|
2010-02-23 |
2012-11-23 |
Sanofi Sa |
Anticuerpos anti - integrina alfa2 y sus usos.
|
US8952054B2
(en)
|
2010-03-15 |
2015-02-10 |
Dana-Farber Cancer Institute, Inc. |
Small molecule inhibitors of MUC1 and methods of identifying the same
|
EP2403855B1
(en)
|
2010-03-22 |
2013-05-01 |
Council of Scientific & Industrial Research |
Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
|
PL2563803T3
(pl)
|
2010-04-27 |
2016-08-31 |
Pharma Mar Sa |
Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8)
|
JP5636091B2
(ja)
|
2010-05-05 |
2014-12-03 |
ウニベルジテート バイロイト |
癌治療に用いるためのコンブレタスタチン類似体
|
CN103003424B
(zh)
|
2010-05-18 |
2015-05-13 |
株式会社医学生物学研究所 |
结合转化生长因子α且对Ras基因突变的癌具有增殖抑制活性的抗体
|
ES2534335T3
(es)
|
2010-05-20 |
2015-04-21 |
Array Biopharma, Inc. |
Compuestos macrocíclicos como inhibidores de la Trk cinasa
|
SG186378A1
(en)
|
2010-06-23 |
2013-01-30 |
Hanmi Science Co Ltd |
Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
|
US8962679B2
(en)
|
2010-07-08 |
2015-02-24 |
The Administrators Of The Tulane Educational Fund |
Daidzein analogs as treatment for cancer
|
WO2012007345A2
(en)
|
2010-07-12 |
2012-01-19 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazo[1,2-a]pyrimidines and -pyridines
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
US20120171694A1
(en)
|
2010-07-30 |
2012-07-05 |
Vermillion, Inc. |
Predictive markers and biomarker panels for ovarian cancer
|
CN103200822B
(zh)
|
2010-08-05 |
2014-12-24 |
天普大学-联邦高等教育体系 |
2-取代-8-烷基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-腈和其应用
|
AU2011292044A1
(en)
*
|
2010-08-18 |
2013-04-04 |
Del Mar Pharmaceuticals |
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
|
WO2012027564A1
(en)
|
2010-08-26 |
2012-03-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
KR101864908B1
(ko)
|
2010-09-01 |
2018-06-05 |
질레드 코네티컷 인코포레이티드 |
피리다지논, 그의 제조 방법 및 사용 방법
|
US8575191B2
(en)
|
2010-09-01 |
2013-11-05 |
Arqule, Inc. |
Methods for treatment of non-small cell lung cancer
|
WO2012030685A2
(en)
|
2010-09-01 |
2012-03-08 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
US8980955B2
(en)
|
2010-09-17 |
2015-03-17 |
Indiana University Research And Technology |
Small molecule inhibitors of replication protein A that also act synergistically with cisplatin
|
US8927562B2
(en)
|
2010-09-28 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
KR101497113B1
(ko)
|
2010-10-20 |
2015-03-03 |
한국생명공학연구원 |
Hif-1 활성을 저해하는 아릴옥시페녹시아크릴계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
SG190204A1
(en)
|
2010-11-11 |
2013-06-28 |
Redx Pharma Ltd |
Drug derivatives
|
CA2817219A1
(en)
|
2010-11-12 |
2012-05-18 |
Endocyte, Inc. |
Methods of treating cancer
|
UY33740A
(es)
|
2010-11-18 |
2012-05-31 |
Takeda Pharmaceutical |
Método para tratar el cáncer de mama y cáncer de ovarios
|
WO2012075362A2
(en)
|
2010-12-03 |
2012-06-07 |
Emory University |
Chemokine cxcr4 receptor modulators and used related thereto
|
WO2012076942A1
(en)
|
2010-12-06 |
2012-06-14 |
Council Of Scientific & Industrial Research |
4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
|
TW201500358A
(zh)
|
2010-12-16 |
2015-01-01 |
Hoffmann La Roche |
三環pi3k抑制劑化合物及其使用方法
|
CA2821984A1
(en)
|
2010-12-17 |
2012-06-21 |
Des R. Richardson |
Thiosemicarbazone compounds and use in the treatment of cancer
|
CN103313992B
(zh)
|
2011-01-12 |
2016-04-27 |
天堃医药科技(杭州)有限公司 |
具有hdac抑制作用的喜树碱衍生物
|
ES2602791T3
(es)
|
2011-01-26 |
2017-02-22 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirrolo tricíclicos, proceso para su preparación y su uso como inhibidores de cinasa
|
WO2012103456A2
(en)
|
2011-01-27 |
2012-08-02 |
Board Of Regents, The University Of Texas System |
Polycyclic beta lactam derivatives for the treatment of cancer
|
PE20140293A1
(es)
|
2011-01-31 |
2014-03-19 |
Novartis Ag |
Novedosos derivados heterociclicos
|
EP2678682A4
(en)
|
2011-02-24 |
2014-10-01 |
Vermillion Inc |
BIOLOGICAL MARKERS PANEL, DIAGNOSTIC METHODS AND TESTING NEEDS FOR OVARIAN CANCER
|
MX2013009551A
(es)
|
2011-02-24 |
2013-09-06 |
Jiangsu Hanson Pharmaceutical Co Ltd |
Compuestos que contienen fosforo como inhibidores de proteina cinasa.
|
WO2012116328A2
(en)
|
2011-02-24 |
2012-08-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
|
JP2014511389A
(ja)
|
2011-02-28 |
2014-05-15 |
エピザイム インコーポレイテッド |
置換6,5−縮合二環式ヘテロアリール化合物
|
DK3031812T3
(en)
|
2011-03-01 |
2018-09-17 |
NuCana plc |
CHEMICAL COMPOUNDS
|
ES2734673T3
(es)
|
2011-03-02 |
2019-12-11 |
Nestle Sa |
Predicción de la sensibilidad farmacológica de tumores de pulmón basándose en identificaciones moleculares y genéticas
|
JP6239979B2
(ja)
|
2011-03-04 |
2017-11-29 |
ニューヨーク・ユニバーシティ |
Rasの調節因子としての水素結合代替大環状分子
|
US8748470B2
(en)
|
2011-03-17 |
2014-06-10 |
The University Of Chicago |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
|
US20140357605A1
(en)
|
2012-03-22 |
2014-12-04 |
Bristol-Myers Squibb Company |
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
|
WO2012138537A1
(en)
|
2011-04-01 |
2012-10-11 |
Immunogen, Inc. |
Compositions and methods for treatment of ovarian, peritoneal, and fallopian tube cancer
|
US8933116B2
(en)
|
2011-04-04 |
2015-01-13 |
Merck Sharp & Dohme Corp. |
Gamma secretase inhibitors
|
ES2579855T3
(es)
|
2011-06-24 |
2016-08-17 |
Arqule, Inc. |
Compuestos de imidazopiridinil-aminopiridina sustituidos
|
MY161925A
(en)
|
2011-07-27 |
2017-05-15 |
Astrazeneca Ab |
2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
|
US9499530B2
(en)
|
2011-08-01 |
2016-11-22 |
Hangzhou Minsheng Institutes For Pharma Research |
Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
|
WO2013020062A1
(en)
|
2011-08-04 |
2013-02-07 |
Array Biopharma Inc. |
Quinazoline compounds as serine/threonine kinase inhibitors
|
CN103097369B
(zh)
|
2011-08-10 |
2014-09-17 |
杨震 |
化学合成安卓幸的方法及其抑制非小细胞肺癌的应用
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
UA111231C2
(uk)
|
2011-09-19 |
2016-04-11 |
Сігма-Тау Індустріє Фармасьютіке Ріуніте С.П.А. |
Тіопохідні лактамів як високоактивні інгібітори hdac та їх застосування як лікарського засобу
|
US20140309184A1
(en)
|
2011-09-21 |
2014-10-16 |
University Of South Alabama |
Methods and compositions for the treatment of ovarian cancer
|
CA2849169C
(en)
|
2011-09-22 |
2019-07-02 |
Merck Sharp & Dohme Corp. |
Pyrazole carboxamides as janus kinase inhibitors
|
WO2013046136A1
(en)
|
2011-09-27 |
2013-04-04 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
AR088075A1
(es)
|
2011-09-28 |
2014-05-07 |
Euro Celtique Sa |
Derivados de mostaza de nitrogeno
|
CN104039797B
(zh)
|
2011-10-12 |
2016-06-01 |
南京奥昭生物科技有限公司 |
作为细胞凋亡诱导剂的杂环分子
|
CN103958508B
(zh)
|
2011-10-14 |
2019-02-12 |
艾伯维公司 |
用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂
|
WO2013062943A1
(en)
|
2011-10-24 |
2013-05-02 |
Glaxosmithkline Intellectual Property Development Limited |
New compounds
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
ES2668272T3
(es)
|
2011-11-03 |
2018-05-17 |
Millennium Pharmaceuticals, Inc. |
Administración de inhibidor de enzimas que activa NEDD8 y agente de hipometilación
|
US8729072B2
(en)
|
2011-11-03 |
2014-05-20 |
F. Hoffman-La Roche Ag |
Alkylated piperazine compounds
|
US20140275174A1
(en)
|
2011-11-10 |
2014-09-18 |
Memorial Sloan-Kettering Cancer Center |
TREATMENT OF OVARIAN CANCER WITH 2-AMINO-4H-NAPHTHO[1,2-b]PYRAN-3-CARBONITRILES
|
EP2776029A1
(en)
|
2011-11-10 |
2014-09-17 |
Memorial Sloan-Kettering Cancer Center |
Treatment of ovarian cancer with benzylidenebenzohydrazides
|
CA2850559C
(en)
|
2011-11-11 |
2016-11-29 |
Eli Lilly And Company |
Combination therapy for ovarian cancer
|
RU2014125230A
(ru)
|
2011-11-22 |
2015-12-27 |
ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Пиридонамиды и их аналоги, демонстрирующие противораковую и антипролиферативную активность
|
US9376469B2
(en)
|
2011-12-21 |
2016-06-28 |
New York University |
Proteolytically resistant hydrogen bond surrogate helices
|
US9260435B2
(en)
|
2012-01-10 |
2016-02-16 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazopyrazines as Akt kinase inhibitors
|
MX350432B
(es)
|
2012-01-19 |
2017-09-06 |
Agios Pharmaceuticals Inc |
Compuestos terapeuticamente activos y sus metodos de empleo.
|
CN115813902A
(zh)
*
|
2012-01-20 |
2023-03-21 |
德玛公司 |
经取代的己糖醇类用于治疗恶性肿瘤的用途
|
MY165215A
(en)
|
2012-01-31 |
2018-03-09 |
Daiichi Sankyo Co Ltd |
Pyridone derivatives
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
CA2865420C
(en)
|
2012-03-06 |
2020-06-02 |
Cephalon, Inc. |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
|
WO2013138665A1
(en)
|
2012-03-16 |
2013-09-19 |
Sanford-Burnham Medical Research Institute |
Inhibitors of furin and other pro-protein convertases
|
AU2013235596B9
(en)
|
2012-03-20 |
2017-12-14 |
Amgen Inc. |
Combination therapy of a MEK inhibitor and IGF1R inhibitor
|
BR112014024251A8
(pt)
|
2012-03-30 |
2018-01-23 |
Rhizen Pharmaceuticals S A |
novos compostos piridina 3,5-dissubstituída-3h-imidazo [4,5-b] e piridina 3,5-dissubstituída -3h-[1,2,3]triazolo[4,5-b] como moduladores de quinases de proteína c-met
|
US10280168B2
(en)
|
2012-03-30 |
2019-05-07 |
Agency For Science, Technology And Research |
Bicyclic heteroaryl derivatives as MNK1 and MNK2 modulators and uses thereof
|
WO2013152301A1
(en)
|
2012-04-05 |
2013-10-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
O-glycan pathway ovarian cancer signature
|
US20150087628A1
(en)
|
2012-04-10 |
2015-03-26 |
The Regents Of The University Of California |
Compositions and methods for treating cancer
|
US8975398B2
(en)
|
2012-05-11 |
2015-03-10 |
Abbvie Inc. |
NAMPT inhibitors
|
JP2015518053A
(ja)
|
2012-05-31 |
2015-06-25 |
アムジエン・インコーポレーテツド |
癌の治療のためのamg900の使用
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
MX367055B
(es)
*
|
2012-06-26 |
2019-08-02 |
Del Mar Pharmaceuticals |
El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa.
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
JP6420247B2
(ja)
|
2012-11-13 |
2018-11-07 |
ボーイエン セラピューティクス,インコーポレイティド |
ゲムシタビンプロドラッグ及びその使用
|
TW201438736A
(zh)
|
2012-11-14 |
2014-10-16 |
Regeneron Pharma |
以dll4拮抗劑治療卵巢癌之方法
|
US8946246B2
(en)
|
2012-11-16 |
2015-02-03 |
New Mexico Technical Research Foundation |
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
|
EP2928471B1
(en)
|
2012-12-06 |
2020-10-14 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
RU2690663C2
(ru)
|
2012-12-20 |
2019-06-05 |
Мерк Шарп И Доум Корп. |
Замещенные имидазопиридины в качестве ингибиторов hdm2
|
CA2894130A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
US11639333B2
(en)
|
2012-12-21 |
2023-05-02 |
Celgene Quanticel Research, Inc |
Histone demethylase inhibitors
|
SG11201506243XA
(en)
|
2013-02-14 |
2015-09-29 |
Bristol Myers Squibb Co |
Tubulysin compounds, methods of making and use
|
TW201444843A
(zh)
|
2013-03-11 |
2014-12-01 |
Abbvie Inc |
溴區結構域蛋白抑制劑
|
CA2901929A1
(en)
|
2013-03-13 |
2014-10-02 |
Abbvie Inc. |
Cdk9 kinase inhibitors
|
EP2970289A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
WO2014143242A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US10413538B2
(en)
|
2013-05-08 |
2019-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer
|
US20140371158A1
(en)
|
2013-06-14 |
2014-12-18 |
Georgia Regents University |
Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway
|
AU2014100435A4
(en)
|
2013-06-17 |
2014-05-29 |
Macau University Of Science And Technology |
A novel treatment of Gefitinib-resistant non-small-cell lung cancer
|
EP3016943B1
(en)
|
2013-07-03 |
2019-08-21 |
F. Hoffmann-La Roche AG |
Heteroaryl pyridone and aza-pyridone amide compounds
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
US9249151B2
(en)
|
2013-08-23 |
2016-02-02 |
Boehringer Ingelheim International Gmbh |
Bis-amido pyridines
|
US9278978B2
(en)
|
2013-08-23 |
2016-03-08 |
Boehringer Ingelheim International Gmbh |
6-Alkynyl Pyridine
|
US20150065526A1
(en)
|
2013-09-05 |
2015-03-05 |
Emory University |
Overcoming acquired resistance to chemotherapy treatments through suppression of stat3
|
US8927717B1
(en)
|
2014-02-14 |
2015-01-06 |
National Defense Medical Center |
Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
|